Shervin (Seyedtaghi) Takyar, MD, PhD

Associate Professor Term

Research Interests

Asthma; Immunity, Cellular; Macrophage Activation; Neoplasms; Angiogenesis Inhibitors; MicroRNAs; Vascular Endothelial Growth Factor A

Research Organizations

Faculty Research

Takyar Lab

Yale Cancer Center: Developmental Therapeutics

Office of Cooperative Research

Research Summary

My research is focused on understanding the molecular basis of a variety of lung disease ranging from asthma to lung cancer. I study the role of a recently discovered group of genes called non-coding RNAs (ncRNAs). These molecules are expressed in the cells, but rather than coding a specific protein, target and modify the expression of other RNAs including messenger RNAs (mRNAs).

In our workflow we first measure the levels of coding and non-coding RNAs in human samples and animal models to identify changes in ncRNAs and candidate target genes that are unique to a specific lung pathology. We then analyze the relationship between these regulatory elements through various bioinformatic and biochemical methods. Finally, we directly investigate the role of these ncRNAs and their targets by modulating their expression in disease models and testing their effects on specific pathogenic mechanisms.

One of our main research interests in recent years has been the role of ncRNAs in the lung endothelium. We are trying to answer questions such as how and why vascular cells become inflamed in diseases like asthma and how activation of these cells permits the propagation of cancerous cells in the lung. In our investigations we found that the levels of a specific small ncRNA; microRNA-1 ( miR-1), closely corresponds with the severity of vascular involvement in inflammation and cancer models. Using various molecular tools we identified a genuine target of miR-1 in lung endothelial cells and have so far shown that modulation of miR-1 or its target in asthma models inhibits the lung inflammatory response. We are currently examining the role of miR-1 in lung cancer. Recently we have expanded the scope our work and are currently examining the effect of miR-1 and a number of other ncRNAs in other lung diseases such as emphysema and lung injury.

Extensive Research Description

The overall goal of my research program is to determine the role of non-coding RNAs in the lung pathologies. My background is in basic molecular biology with a focus on RNA biochemistry and structural biology. We have established the basic experimental tools necessary for the identification and modulation of expression of non-coding RNAs in various cellular compartments of the lung.

We have found that miR-1 is specifically down-regulated by VEGF through VEGF receptor- 2 in the lung endothelium and mediates the angiogenic and inflammatory effects of VEGF. We have shown that miR-1 selectively controls the proliferative pathways downstream from VEGF and directly down-regulates the expression of Myeloproliferative Leukemia Oncogene (Mpl) mRNA by recruiting it to RISC (RNA Induced Silencing Complex). We have also found that, through regulation of Mpl, miR-1 controls the expression of adhesion molecules, namely P-selectin, on the lung endothelium, recruitment of Tcells, and severity of lung Th2 inflammation. We have developed vector-based and transgenic models for cell-specific expression of miRNAs and their targets in the lung. Using these tools, we have shown that miR-1/Mpl axis controls VEGF-mediated effects in lung angiogenesis and Th2 inflammation. These findings are not limited to animal models, and miR-1 is also regulated by VEGF and controls Mpl gene in human endothelial cells.

We have developed two experimental models for studying the role of miRNAs in tumor progression and metastasis and are currently working on the molecular mechanism of miR-1 down-regulation in the endothelium. Recently we have expanded our studies to the other lung pathologies where VEGF plays a major role. In our collaboration with Dr. Patty Lee we are investigating the role of VEGF and VEGF-induced miRNAs in lung injury and COPD.

We collaborate with J.Steitz, Sterling Professor of Molecular Biophysics and Biochemistry and HHMI (Howard Hughes Medical Institute) at Yale on the molecular aspects of our projects. We have also started a collaboration with the Dr D. Boffa, Dr J. Puchalski and Dr M. Pisani at Thoracic Oncology Program (TOP), Thorciac Interventional Program, and Pulmonary and Critical Care section respectively. Through this collaboration we collect samples from resected lung tumors for their miRNA content, and analyze the correlation of miRNA expression with lung tumor progression.

- The role of miR-1 in mediating the VEGF-mediated angiogeneis and vascular activation in the lung

-The role of VEGF/miR-1 axis in Th2 adaptive Immunity

-The effect of TLR4-related non-coding RNAs on VEGF signaling in the lung

-The role of microRNA in the Activation of Macrophages

Selected Publications

Full List of PubMed Publications

Edit this profile

Contact Info

Shervin (Seyedtaghi) Takyar, MD, PhD
Patient Care Locations
Winchester Chest ClinicFitkin Memorial Pavilion
789 Howard Avenue, Ste 2nd Floor

New Haven, CT 06519
View on map...
Yale Pulmonary & Critical Care MedicineYale New Haven Hospital
20 York Street

New Haven, CT 06510
View on map...
Mailing Address
PO Box 208057
300 Cedar Street

New Haven, CT 06520-8057

Curriculum Vitae

Takyar Lab